Wednesday, July 8, 2026

Drug profile · INN

collagenase

collagenase (SANTYL) is a collagen hydrolytic enzyme. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 1
News articles 0
Drug details — collagenase
US status
approved
Class
Route
TOPICAL
Patents
1
Programs
1
Data quality
0.84

Quick answer

collagenase (SANTYL) is a collagen hydrolytic enzyme. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN collagenase
Brand SANTYL
Mechanism Collagen hydrolytic enzyme
Target Collagen
Route TOPICAL
Formulation OINTMENT

Mechanism of action

Collagen hydrolytic enzyme

Primary target: Collagen

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. Colla corii asini Approved · Chinese Academy of · Thalassemia

Related & competitor drugs

  1. beremagene geperpavec Dermatologicals (D03)
  2. collagenase clostridium histolyticum Musculo-skeletal system (M09)
  3. collagenase clostridium histolyticum-aaes Collagen hydrolytic enzyme
  4. doxycycline calcium Matrix metalloproteinase 8 inhibitor
  5. ocriplasmin Sensory organs (S01)
  6. collagenase (clostridium histolyticum) Collagen hydrolytic enzyme

Related patents

  1. US 8486898

    Compounds and method for inhibiting the activity of gelatinase and collagenase

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is collagenase?

collagenase (SANTYL) is a collagen hydrolytic enzyme. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for collagenase?

SANTYL is a marketed brand name for collagenase. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of collagenase?

collagenase has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.